Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Distal 17p13.1 microdeletion syndrome is a rare chromosomal anomaly syndrome characterized by mild global developmental delay/intellectual disability with poor to absent speech, dysmorphic features (long midface, retrognathia with overbite, protruding ears), microcephaly, failure to thrive, wide-based gait and a body posture with knee and elbow flexion and hands held in a midline.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for distal 17p13.1 microdeletion syndrome.
3 publications have been identified in PubMed for distal 17p13.1 microdeletion syndrome. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).
van Kampen F (2025). [PMID: 39966556](https://pubmed.ncbi.nlm.nih.gov/39966556/). *Oncogene*. [Basic Science / Preclinical]
Bonati MT (2024). [PMID: 38927613](https://pubmed.ncbi.nlm.nih.gov/38927613/). *Genes*. [Case Report / Case Series]
Bartek V (2024). [PMID: 39062246](https://pubmed.ncbi.nlm.nih.gov/39062246/). *Children (Basel, Switzerland)*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center